Skip to main content
Contact Us
Subscribe
E-Edition
41°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tevogen Bio Holdings Inc. - Common Stock
(NQ:
TVGN
)
1.640
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tevogen Bio Holdings Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Friday's Intraday Session
October 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 17, 2024
Via
Benzinga
Why Is Small-Cap Tevogen Bio Stock Rocketing Higher On Thursday?
October 17, 2024
evogen Bio projects strong revenue for its oncology pipeline and reports positive phase 1 trial data for its COVID-19 therapy. The company's stock is trading higher amid increased volume.
Via
Benzinga
Exposures
COVID-19
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
October 17, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Investors Congratulate on Prestigious Recognition of Pioneering Biopharma Business Model, Breakthrough Innovations, Building Assets Estimated to Exceed $10 Billion
October 17, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality
October 16, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 15, 2024
Via
Benzinga
Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions
October 15, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Highlights the Publication of Promising Trial Data as the CEO Expresses Optimism About the Company’s Scientific Breakthrough in Mainstreaming Cell Therapy Through a New Class of Off-the-Shelf T-Cell Therapies, Manufactured and Stored for
October 15, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
October 15, 2024
Via
Benzinga
Tevogen CEO Reaffirms the Company’s Commitment to Closing the Information Gap on Its Multi-Billion-Dollar Assets, Following the Release of Revenue Projections
October 14, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump
October 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
October 14, 2024
Via
Benzinga
Crude Oil Down Over 2%; Verb Technology Shares Spike Higher
October 14, 2024
Via
Benzinga
Exposures
Fossil Fuels
Leaders in The News: BigBear.ai, Luminar, New World Solutions, Tevogen Bio
October 14, 2024
Latest Advances in AI for Military, Biotech, Electric Vehicles and Digital Transformation of $31 Billion Watch Market
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nasdaq Surges 1%; Boeing Reports 10% Workforce Reduction
October 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 14, 2024
Via
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
October 14, 2024
Via
Benzinga
A Lot Of Home Runs And One Ugly Strikeout; One New Swing Position
October 12, 2024
In this video, I review some amazing trades, one missed entry non-trade, a losing trade, and how not taking a high conviction trade can ruin them all.
Via
Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
October 11, 2024
Via
Benzinga
Tevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024
October 11, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Extends Pipeline Prioritizing Oncology and Long COVID
October 11, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 10, 2024
Via
Benzinga
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
October 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 09, 2024
Via
Benzinga
Tevogen Bio Highlights Promising Trial Data as CEO Leads Patient Advocacy at Capitol Hill, Pledging to Leverage Multi-Billion Dollar Company Assets to Combat Long COVID and Spearhead a New Wave of Medical Innovation
October 08, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 08, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
